Press Releases
 
Bone Morphogenetic Protein Market On Global Industry Analysis and Trends till 2027

, 14 November 2017 -- Bone Morphogenetic Protein Market - Global industry segment analysis, regional outlook, share, growth; bone morphogenetic protein market forecast 2017 to 2027 by future market insights

Bone morphogenetic protein (BMPs) is the group of growth factors that belong to beta super family (TGF beta). These proteins are naturally occurring proteins. The family of this protein is involved in various cellular responses. Certain bone morphogenetic protein are said to induce the formation of bones and cartilage that is they are osteoinductive. Many types of bone morphogenetic proteins are discovered, however only BMP 2, 4, 6, 7 and 9 are said to play a significant role in bone formation. Recombinant bone morphogenetic protein mainly, rh BMP-2 and rh-BMP-7 are used in orthopedic applications such as spinal fusions and oral surgery. These recombinant proteins are approved for the mentioned application. It is believed that recombinant morphogenetic protein known as rh-BMP-7 can be used in certain kidney diseases.

Request for TOC @

https://www.futuremarketinsights.com/toc/rep-gb-2980

The bone morphogenetic protein has proved to be useful for the patient undergoing spinal infusion treatment because of the elimination of pain. This advanced approach reduces the amount of pain, reduces the dependence on screw and spinal rods and has increased the rate of spinal fusion, which has will lead to increase in the global bone morphogenetic protein market through 2024. Additionally, increase in number of accidents, spinal and bone injuries, rise in number of sports injuries, secondary lifestyle such as bad postures, increases in geriatric population are the major factors that are likely to propel the growth of the global bone morphogenetic protein market during the forecast period. However, the increase in cost of the bone morphogenetic protein product, strict regulations issues, biocompatibility factor involved during the transplantation and the availability of the well established alternative bone grafts are few of the factors that can restrain the growth of the global bone morphogenetic protein market during the forecast period.

The global bone morphogenetic market is segmented into types of recombinant protein, application types and geography. On the basis of the type of recombinant protein the global market is segmented into rh-BMP-2, rh- BMP-7 and others. rh- BMP-2 segment dominates the global market due to large acceptance of the protein by the physicians and surgeons globally, rise in number of sports injuries, favorable reimbursement policies etc. rh-BMP-7 is expected to diminish from the global market in future. On the basis of application the global market is divided into spinal fusion, trauma, oral surgery, maxilla-facial defects and others. The spinal fusion segment holds the largest share in the global market owing to the factors like rise in spinal injuries, rise in geriatric population, rise in sports injuries etc.

Geographically, the global bone morphogenetic protein market is divided into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific excluding Japan, Japan, Middle East and Africa. North America region is expected to dominate the global bone morphogenetic protein market through 2024 followed by Europe. Rise in prevalence of spinal injuries, prevalence of unhealthy lifestyle, awareness of protein product, and rise in geriatric population. Asia Pacific region is expected to register a higher growth in the global bone morphogenetic protein market due to awareness among the people about bone morphogenetic protein, rise in number of accidents, developing research and technology, rise in healthcare spending capacity, rise in medical tourism in countries such as China and India etc.

Bone Morphogenetic Protein Market: Players

Some of the major players operating in the global bone morphogenetic protein market are Medtronic, Cellumed Co.Ltd, Sigma-Aldrich Corporation, ProSpec, Ember Therapeutics, DePuy Synthesis among others worldwide. To maintain a significant position in the global market the key players are operating strategies like producing cost effective and efficient product. INFUSE which is manufactured by Medtronic is approved bone morphogenetic protein. It is the most widely accepted product and account for the largest share of the company.

Request to view Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2980

# # #


Media Contacts:
Contact Us

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email:sales@futuremarketinsights.com

Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 14 November 2017 at 7:42 PM
Category: Health Care & Medical
 
Related News

“Hydrabelle” Vitality Serum For Women : Scam or Legit?
Friday, 23 Feb 2018

Cord Blood Banking Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forec
Thursday, 22 Feb 2018

Lymphangioleiomyomatosis Global Clinical Trials Review H2 2017: Ken Research
Thursday, 22 Feb 2018

Global Lyme Disease Clinical Trials Market Research Report: Ken Research
Thursday, 22 Feb 2018

Companion Diagnostics Market: Easing of Regulatory Policies to Drive the Demand
Thursday, 22 Feb 2018

Related Events

Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Wednesday, 21 Feb 2018

DNA and Interacting Proteins as Single Molecules - In Vitro and In Vivo
Wednesday, 21 Feb 2018

The 5th International Congress on Cardiac Problems in Pregnancy (CPP 2018)
Thursday, 22 Feb 2018

RSM Aesthetics 10
Friday, 23 Feb 2018

One Day of Cardiotocography
Friday, 23 Feb 2018

Latest News

5 Benefits of the Custom T-Shirt
Friday, 23 Feb 2018

meditation for beginners
Friday, 23 Feb 2018

Wholesale Distributors Of Reading Glasses And Sunglasses In Europe
Friday, 23 Feb 2018

Why You will need SEO Services for Online Business
Friday, 23 Feb 2018

Finding the Best Cars for Sale in Winston Salem NC
Friday, 23 Feb 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Friday, 23 February 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
  • DNA and Interacting Proteins as Single Molecules - In Vitro and In Vivo
  • What should be paid attention to in the ultrafine grinding process?
  • Palo Alto Networks: Customer Product Council - Frankfurt
  • The 5th International Congress on Cardiac Problems in Pregnancy (CPP 2018)

  • Latest Jobs
    Sorry, there are currently no entries posted here.